Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To ...
Summary by Enid News & Eagle
3 Articles
3 Articles


Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To ...
LA PALMA, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced that its Board of Directors and executive team have formally initiated a…
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium